82 results on '"de Leval, Laurence"'
Search Results
2. Immune Phenotype-Genotype Associations in Primary Clear Cell Renal Cell Carcinoma and Matched Metastatic Tissue
3. PD1 inhibits PKCθ-dependent phosphorylation of cytoskeleton-related proteins and immune synapse formation
4. Oral azacitidine compared with standard therapy in patients with relapsed or refractory follicular helper T-cell lymphoma (ORACLE): an open-label randomised, phase 3 study
5. Follicular Lymphoma Presenting With Symptomatic Bone Involvement: A Clinicopathologic and Molecular Analysis of 16 Cases
6. HIV infection is associated with compromised tumor microenvironment adaptive immune reactivity in Hodgkin lymphoma
7. A practical approach to the modern diagnosis and classification of T- and NK-cell lymphomas
8. Multilevel human secondary lymphoid immune system compartmentalization revealed by complementary imaging approaches
9. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
10. Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations
11. Overcoming IMiD resistance in T-cell lymphomas through potent degradation of ZFP91 and IKZF1
12. Genetic and phenotypic attributes of splenic marginal zone lymphoma
13. Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma
14. An update on the pathology of extranodal T-cell lymphomas
15. Approach to nodal-based T-cell lymphomas
16. Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry
17. CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1− mantle cell lymphoma
18. Microfluidics for rapid cytokeratin immunohistochemical staining in frozen sections
19. Microfluidics-assisted fluorescence in situ hybridization for advantageous human epidermal growth factor receptor 2 assessment in breast cancer
20. Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell–derived lymphomas
21. P-182 - KIR3DL2 also represents a novel therapeutic target in non-cutaneous aggressive systemic peripheral T-cell lymphomas
22. Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype
23. Mature T-cell lymphomas
24. Lymphoblastic transformation of follicular lymphoma: a clinicopathologic and molecular analysis of 7 patients
25. Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma
26. ITMIG Consensus Statement on the Use of the WHO Histological Classification of Thymoma and Thymic Carcinoma: Refined Definitions, Histological Criteria, and Reporting
27. Genomic profiling for clinical decision making in lymphoid neoplasms
28. Oral Azacytidine in Patients with Relapsed/Refractory Angioimmunoblastic T-Cell Lymphoma: Final Analysis of the Oracle Phase III Study
29. Addition of Brentuximab Vedotin to Gemcitabine in Relapsed or Refractory T-Cell Lymphoma: Final Analysis of a Lysa Multicenter, Phase II Study. "the TOTAL Trial"
30. Frequent Alterations of Driver Genes in Chromosome X and Their Clinical Relevance in Extranodal NK/T-Cell Lymphoma
31. Clinicopathologic analysis of acute myeloid leukemia arising from chronic myelomonocytic leukemia
32. Molecular underpinning of extranodal NK/T-cell lymphoma
33. Impact of bone marrow-derived mesenchymal stromal cells on experimental xenogeneic graft-versus-host disease
34. Cytokine-pathway blockers worsen mycosis fungoides masquerading as psoriasis
35. Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets
36. New biomarkers in T-cell lymphomas
37. Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study
38. Herpesvirus-Associated B-cell Proliferations
39. Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type
40. Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma
41. Immunomodulator agent-related lymphoproliferative disorders
42. TCL-473 Role of Microsatellite Instability in the Oncogenesis of Primary Intestinal T-Cell Lymphomas
43. TCL-330 RHOA G17V Potentiates CD28-Induced NFAT Transcriptional Activity by Modulating p300 Activity: A Step Further in the Understanding of Follicular Helper T-Cell Lymphoma
44. POSTER: TCL-473 Role of Microsatellite Instability in the Oncogenesis of Primary Intestinal T-Cell Lymphomas
45. POSTER: TCL-330 RHOA G17V Potentiates CD28-Induced NFAT Transcriptional Activity by Modulating p300 Activity: A Step Further in the Understanding of Follicular Helper T-Cell Lymphoma
46. EXABS-214-TCL New Insights Into the Pathogenesis of T-Cell Lymphoma and How This May Guide Treatment
47. Characterization of an antibody panel for immunohistochemical analysis of canine muscle cells
48. TARC and IL-5 expression correlates with tissue eosinophilia in peripheral T-cell lymphomas
49. Early inflammation in the airways of a cystic fibrosis foetus
50. Activation of the Thromboxane A2 Pathway in Human Prostate Cancer Correlates with Tumor Gleason Score and Pathologic Stage
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.